pioglitazone has been researched along with Carcinoma in 3 studies
Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.
Carcinoma: A malignant neoplasm made up of epithelial cells tending to infiltrate the surrounding tissues and give rise to metastases. It is a histological type of neoplasm and not a synonym for cancer.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pioglitazone was suspended for manufacture and sale by the Indian drug regulator in June 2013 due to its association with urinary bladder carcinoma, which was revoked within a short period (July 2013)." | 3.85 | Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study. ( Adhikari, A; Ambwani, S; Badyal, DK; Bairy, KL; Bhandare, B; Chakrabarti, A; Chandrashekar, K; Das, N; Dhamija, P; Dhasmana, DC; Goyal, A; Goyal, C; Gupta, YK; Jayanthi, CR; Kakkar, AK; Kaur, I; Kaushal, S; Kumar, R; Mazumdar, G; Munshi, R; Rehman, SU; Sarangi, SC; Sehgal, VK; Singh, H; Singh, J; Stephy, DJ; Thangaraju, P, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Goyal, A | 1 |
| Singh, H | 1 |
| Sehgal, VK | 1 |
| Jayanthi, CR | 1 |
| Munshi, R | 1 |
| Bairy, KL | 1 |
| Kumar, R | 1 |
| Kaushal, S | 1 |
| Kakkar, AK | 1 |
| Ambwani, S | 1 |
| Goyal, C | 1 |
| Mazumdar, G | 1 |
| Adhikari, A | 1 |
| Das, N | 1 |
| Stephy, DJ | 1 |
| Thangaraju, P | 1 |
| Dhasmana, DC | 1 |
| Rehman, SU | 1 |
| Chakrabarti, A | 1 |
| Bhandare, B | 1 |
| Badyal, DK | 1 |
| Kaur, I | 1 |
| Chandrashekar, K | 1 |
| Singh, J | 1 |
| Dhamija, P | 1 |
| Sarangi, SC | 1 |
| Gupta, YK | 1 |
| Antonelli, A | 1 |
| Ferrari, SM | 1 |
| Fallahi, P | 1 |
| Berti, P | 1 |
| Materazzi, G | 1 |
| Minuto, M | 1 |
| Giannini, R | 1 |
| Marchetti, I | 1 |
| Barani, L | 1 |
| Basolo, F | 1 |
| Ferrannini, E | 1 |
| Miccoli, P | 1 |
| Burton, JD | 1 |
| Castillo, ME | 1 |
| Goldenberg, DM | 1 |
| Blumenthal, RD | 1 |
3 other studies available for pioglitazone and Carcinoma
| Article | Year |
|---|---|
Impact of regulatory spin of pioglitazone on prescription of antidiabetic drugs among physicians in India: A multicentre questionnaire-based observational study.
Topics: Adult; Aged; Carcinoma; Diabetes Mellitus, Type 2; Female; Humans; Hypoglycemic Agents; India; Male; | 2017 |
Thiazolidinediones and antiblastics in primary human anaplastic thyroid cancer cells.
Topics: Carcinoma; Cell Proliferation; Growth Inhibitors; Humans; Pioglitazone; Rosiglitazone; Thiazolidined | 2009 |
Peroxisome proliferator-activated receptor-gamma antagonists exhibit potent antiproliferative effects versus many hematopoietic and epithelial cancer cell lines.
Topics: Anilides; Antineoplastic Agents; Apoptosis; Benzamides; Carcinoma; Caspase Inhibitors; Caspases; Cel | 2007 |